These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1326916)

  • 1. [Prevention of postoperative recurrence of hepatocellular carcinoma by adjuvant locoregional chemotherapy].
    Izumi R; Shimizu K; Kiriyama M; Ii T; Iwasa K; Iyobe T; Masutani H; Yagi M; Miyazaki I; Matsui O
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1497-500. PubMed ID: 1326916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy].
    Endo Y; Tani T; Kawaguchi A; Eguchi Y; Sano H; Kurumi Y; Hanasawa K; Ishibashi H; Terata N; Shibata J
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1535-7. PubMed ID: 8396906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of postoperative adjuvant arterial infusion chemotherapy in resected hepatoma patients].
    Nakashima K; Aramaki M; Yoshida T; Kim YI; Kitano S; Kobayashi M; Suzuki K; Aikawa H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1481-4. PubMed ID: 8396901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic chemotherapy by regional arterial infusion in resected hepatoma patients].
    Nakashima K; Kim YI; Okada K; Iwao Y; Aramaki M; Kobayashi M; Aikawa H; Suzuki K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1489-92. PubMed ID: 1326914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
    Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative arterial infusion chemotherapy for hepatocellular carcinoma].
    Itamoto T; Asahara T; Okamoto Y; Nakahara H; Katayama K; Nomura S; Marubayashi S; Yahata H; Fukuda Y; Dohi K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1493-6. PubMed ID: 1326915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Miyazaki I
    Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer].
    Isshiki K; Nonami T; Kishimoto W; Katoh H; Akaza K; Harada A; Nakao A; Takagi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1634-7. PubMed ID: 2167638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension].
    Takeda M; Mizuguchi N; Ohyama Y; Suzuki S; Itoh M; Mukojima T; Kumagai T; Iwasaki H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1367-70. PubMed ID: 1648891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of prophylactic transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Togo S; Tanaka K; Masui H; Matsuo K; Morioka D; Kurosawa H; Miura Y; Endo I; Sekido H; Shimada H
    Int Surg; 2005; 90(2):103-8. PubMed ID: 16119716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic chemolipiodolization for postoperative hepatoma patients.
    Shimoda M; Bando T; Nagata T; Shirosaki I; Sakamoto T; Tsukada K
    Hepatogastroenterology; 2001; 48(38):493-7. PubMed ID: 11379340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
    Li JQ; Zhang YQ; Zhang WZ
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):387-9. PubMed ID: 7895595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postoperative adjuvant intraarterial chemotherapy of combined cisplatin and 5-FU for advanced hepatocellular carcinoma].
    Kamiyama T; Nakagawa T; Nakanishi K; Kurauchi N; Kamachi H; Matsushita M; Todo S
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1618-20. PubMed ID: 14619478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.